Doctors prescribing weight loss drug not yet approved by FDA, CBS News investigation finds
✨ AI Summary
🔊 جاري الاستماع
The weight loss drug retatrutide has been touted as "Ozempic on steroids." It's still in clinical trials and not approved by the FDA, but a CBS News investigation found that hasn't stopped doctors from offering it, and it could come with serious side effects. Adam Yamaguchi reports.
